Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTianjin Huanhu Hospital
About this trial
The objective of this study is to create a comprehensive, real-world, multi-center observational registry of consecutive patients admitted to hospitals with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO), who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).
Eligibility criteria
Qualifiers
Patient admitted from Jan. 1st 2018 to Jan. 1st 2028;
Age ≥ 18;
Ischemic stroke confirmed by head CT or MRI;
Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1/P2);
Disqualifiers
None
Trial design
Treatments tested in this trial
- Endovascular Therapy
Treatment groups
5,000 Participants
are divided into 2 treatment groupsLocations
4Beijing University Binhai Hospital300450, TianjinTianjin Municipality, China
The Sencond Hospital of Tianjin Medical University300211, TianjinTianjin Municipality, China
Tianjin Huanhu Hospital300222, TianjinTianjin Municipality, China
Tianjin Medical University General Hospital300052, TianjinTianjin Municipality, China
Sponsors and collaborators
Tianjin Huanhu Hospital
Lead sponsor
Source ClinicalTrials.gov